Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yu Wang, Weiwei Song, Qiang Xu, Yachao Liu, Hezhong Liu, Runzi Guo, Chuang-Jiun Chiou, Kun Gao, Baofeng Jin, Changfeng Chen, Zhongming Li, Jinqi Yan & Jiyun Yu. (2023) Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
AJ Graves & DA Hokey. (2015) Tuberculosis vaccine development: Shifting focus amid increasing development challenges. Human Vaccines & Immunotherapeutics 11:8, pages 1910-1916.
Read now
Read now
Hu Liu, Shuang Geng, Congcong Feng, Xiaoping Xie, Bing Wu, Xuan Chen, Qiang Zou, Shuang Wang, Jiantao Cui, Rui Xing, Wenmei Li, Youyong Lu & Bin Wang. (2013) A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model. Human Vaccines & Immunotherapeutics 9:10, pages 2196-2202.
Read now
Read now
Articles from other publishers (21)
Ichwaku Rastogi, Anusha Muralidhar & Douglas G. McNeel. (2023) Vaccines as treatments for prostate cancer. Nature Reviews Urology.
Crossref
Crossref
Adeline N. Boettcher, Ahmed Usman, Alicia Morgans, David J. VanderWeele, Jeffrey Sosman & Jennifer D. Wu. (2019) Past, Current, and Future of Immunotherapies for Prostate Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Umme K. Rima, Abu S.M. Bari, Mohammad Z. Hossain & Mohammad A.H. Khan. (2018) Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice. Prostate International 6:4, pages 151-156.
Crossref
Crossref
Jing-Yan Tian, Feng-Jun Guo, Guo-You Zheng & Aamir Ahmad. (2018) Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities. Carcinogenesis 39:3, pages 307-317.
Crossref
Crossref
Christine A. Clarke, Michael A. Smith, Ibrahim Laniyan, Theresa R. Vaughn, Debra Parish-Gause, William Green & Paulette M. Furbert-Harris. (2015) Eosinophil MBP Extract Modulates Oncogene Expression in Prostate Tumor Cells: A Preliminary Study with Monolayer Cultures. Journal of Cancer Therapy 06:06, pages 482-492.
Crossref
Crossref
Jonathan W. Simons. (2014) Prostate Cancer Immunotherapy: Beyond Immunity to Curability. Cancer Immunology Research 2:11, pages 1034-1043.
Crossref
Crossref
Michael T. Schweizer & Charles G. Drake. (2014) Immunotherapy for prostate cancer: recent developments and future challenges. Cancer and Metastasis Reviews 33:2-3, pages 641-655.
Crossref
Crossref
Jinming Li, Yanli Sun, Tingting Jia, Rui Zhang, Kuo Zhang & Lunan Wang. (2014) Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer. International Journal of Cancer 134:7, pages 1683-1694.
Crossref
Crossref
Charles H. Jones, Anders P. Hakansson & Blaine A. Pfeifer. (2014) Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design. J. Mater. Chem. B 2:46, pages 8053-8068.
Crossref
Crossref
Dominick L. Auci, Denise L. Cecil, Daniel Herendeen, Elizabeth K. Broussard, John B. Liao, Gregory E. Holt & Mary L. Disis. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
335
343
.
Kouji Kobiyama, Nao Jounai, Taiki Aoshi, Miyuki Tozuka, Fumihiko Takeshita, Cevayir Coban & Ken Ishii. (2013) Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination. Vaccines 1:3, pages 278-292.
Crossref
Crossref
Sakthivel Muniyan, Yu-Wei Chou, Shou-Qiang Ou-Yang & Ming-Fong Lin. 2013. Prostate Cancer. Prostate Cancer
323
348
.
Scott T. Tagawa, Joseph R. Osborne, Shankar Vallabhajosula, Stanley J. Goldsmith & Neil H. Bander. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
459
466
.
Sarfraz Ahmad, Paul Sweeney, Gerald C Sullivan & Mark Tangney. (2012) DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?. Genetic Vaccines and Therapy 10:1.
Crossref
Crossref
Charles G. Drake & Emmanuel S. Antonarakis. (2012) Current status of immunological approaches for the treatment of prostate cancer. Current Opinion in Urology 22:3, pages 197-202.
Crossref
Crossref
Emmanuel S. Antonarakis & Charles G. Drake. (2012) Combining immunological and androgen-directed approaches. Current Opinion in Oncology 24:3, pages 258-265.
Crossref
Crossref
Steven Joniau, Per-Anders Abrahamsson, Joaquim Bellmunt, Carl Figdor, Freddie Hamdy, Paul Verhagen, Nicholas J. Vogelzang, Manfred Wirth, Hendrik Van Poppel & Susanne Osanto. (2012) Current Vaccination Strategies for Prostate Cancer. European Urology 61:2, pages 290-306.
Crossref
Crossref
Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell & Scott T. Tagawa. (2012) Prostate-Specific Membrane Antigen-Based Therapeutics. Advances in Urology 2012, pages 1-9.
Crossref
Crossref
OH Reznikov, LV Chaĭkovs'ka, LI Poliakova & OV Sachyns'ka. (2011) Effects of cytokine-like polypeptide EMAP II and flutamide on the testosterone-stimulated prostate of castrated rats. Fiziolohichnyĭ zhurnal 57:4, pages 12-20.
Crossref
Crossref
Charles G. Drake. (2011) Update on Prostate Cancer Vaccines. The Cancer Journal 17:5, pages 294-299.
Crossref
Crossref
Gisella E. Vittes, Elena L. Harden, Christian H. Ottensmeier, Jason Rice & Freda K. Stevenson. (2011) DNA fusion gene vaccines induce cytotoxic T‐cell attack on naturally processed peptides of human prostate‐specific membrane antigen. European Journal of Immunology 41:8, pages 2447-2456.
Crossref
Crossref